| |
|
|
| |
|
|
| |
Lewis L. Hsu, MD, PhD
|
|
Request an
Appointment
|
The Center for Cancer and Blood Disorders
Departments
Hematology
Programs
Director, Sickle Cell Disease Program
Children’s Research Institute (CRI)
Center for Cancer and Immunology Research
Specialties: Sickle Cell Disease, Thalassemia, Anemia (hemolytic)
|
|
| Board Certifications |
American Board of Pediatrics
American Board of Pediatrics
American Board of Pediatrics/Hematology-Oncology
American Board of Pediatrics/Hematology-Oncology
|
| Foreign Languages |
Chinese (Mandarin), Spanish |
National Provider Identifier
 |
1851357388 |
|
| Practice Locations |
Children's National Medical Center - Sheikh Zayed Campus for Advanced Children's Medicine
111 Michigan Avenue, NW
Washington, DC 20010
Map | Driving Directions
Phone: 202-476-5000
|
|
Biography  |
Lewis L. Hsu, MD, PhD, is a pediatric hematologist dedicated to finding cures for sickle cell disease and improving treatment and education about the disease until cures can be found.
Dr. Hsu has clinical research experience in sickle cell stroke prevention, bone marrow transplantation, and lung problems. His lab research examines the deficiency of nitric oxide and nitrite in sickle cell disease. |
|
| Lewis L Hsu in the news |
 Fox5 highlights Children's sickle cell program, that helps kids living with sickle cell disease keep up with their treatment | June 2010
|
|
| Education |
| Type | School | Location | Degree | Field of Study | Years | | Undergraduate Education | Cornell University | Ithaca, NY | Bachelor of Science | | 1977 -1981 | | Medical School | University of Rochester | Rochester, NY | Doctor of Medicine | | 1981 -1988 | | Post Graduate Education | University of Rochester | Rochester, NY | Doctor of Philosophy | | 1981 -1988 |
|
|
| Training |
| Type | Institution | Location | Position | Specialty | Years | | Internship Program | Yale New Haven Children's Hospital | New Haven, CT | Intern | Pediatrics | 1988 - 1989 | | Internship Program | Yale New Haven Children's Hospital | New Haven, CT | Intern | Pediatrics | 1988 - 1989 | | Residency Program | Yale New Haven Children's Hospital | New Haven, CT | Resident | Pediatrics | 1989 - 1991 | | Residency Program | Yale New Haven Children's Hospital | New Haven, CT | Resident | Pediatrics | 1989 - 1991 | | Fellowship Program | Children's Hospital of Philadelphia | Philadelphia, PA | Fellow | Pediatric Hematology/Oncology | 1991 - 1994 | | Fellowship Program | Children's Hospital of Philadelphia | Philadelphia, PA | Fellow | Pediatric Hematology/Oncology | 1991 - 1994 |
|
|
| National and International Recognition |
| Award | Institution | Event | Year | | Medical Student Training Program | National Institutes of Health | | 1981 |
|
|
| Affiliations and Memberships |
| Title | Institution | Committee / Section | Years | | Member | American Society of Hematology | | 1993 - 2009 | | Member | American Society of Pediatric Hematology/Oncology | | 2002 - 2009 | | Member | American Thoracic Society | | 2002 - 2009 | | Member | Regional Consortium for Sickle Cell Guidelines | | 2001 - 2003 |
|
|
| Research |
| Title | Study Name | Institution | Years | | Investigator | Comprehensive Sickle Cell Center, Basic and Translational Research Projects | National Institute of Health | 2008 - 2011 | | | Principal Investigator | A Phase 2a, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, and Efficacy of 6R-BH4 in Subjects with Sickle Cell Disease | BioMarin Pharmaceutical, Inc. | 2007 - 2009 | | | Principal Investigator | Optimizing Lung Function in Hospitalized Children with Sickle Cell Disease | DHD Healthcare, Inc | 2009 - 2009 | | | Investigator | Pilot trial of intravenous nitrite for sickle cell vaso-occlusive pain crisis | National Institue of Health | 2006 - 2008 | | | Investigator | Stem Cell Transplantation for Sickle Cell Disease ("Seattle consortium" clinical study of bone marrow transplantation (BMT) for children with sickle cell disease) | National Institutes of Health | 1993 - 1998 | |
|
|
| Publications |
Journal Article, Wood, K.C., Hsu, L.L., Gladwin, M.T. (2008), Sickle Cell Disease Vasculopathy: A State of Nitric Oxide Resistance, Free Radical and Biology Medicine, 44, 8, 1506-1528.
Journal Article, Hulbert, M.L., Scothorn, D.J., Panepinto, J.A., Scott, J.P., Buchanan, G.R., Sarnaik, S., Fallon, R., Chu, J.Y., Wang, W., Casella, J.F., Resar, L., Berman, B., Adamkiewicz, T., Hsu, L.L., Smith-Whitl (2006), Exchange Blood Transfusion Compared With Simple Transfusion for First Overt Stroke is Associated With a Lower Risk of Subsequent Stroke: a Retrospective Cohort Study of 137 Children With Sickle Cell , Journal of Pediatrics, 149, 5, 710-712.
Book Chapter, Hsu, L. (2006), In Platt, A.F., Sacerdote, A., Hope and Destiny: A Patient's and Parent's Guide to Sickle Cell Disease and Sickle Cell Trai, Roscoe, IL, Hilton Publishing.
Journal Article, Hsu, L.L., Miller, S.T., Kutlar, A., Wright, E., Wang, W., Pegelow, C.H., Driscoll, C., Hurlet, A., Woods, G., Elsas, L., Embury, S., Adams, R. (2003), The Stroke Prevention Trial (STOP) and the Cooperative Study of Sickle Cell Disease (CSSCD). Alpha Thalassemia Is Associated With Decreased Risk Of Abnormal TCD In Children With Sickle Cell Anemia, Journal of Pediatric Hematology/Oncology, 25, 8, 622-628.
Journal Article, Scothorn, D.J., Price, C., Schwartz, D., Terrill, C., Buchanan, G.R., Shurney, W., Sarniak, I., Fallon, R., Chu, J.Y., Pegelow, C.H., Wang, W., Casella, J.F., Resar, L.S., Berman, B., Adamkiewicz, T., (2002), Risk of Recurrent Stroke in Children With Sickle Cell Disease Receiving Blood Transfusion Therapy For at Least Five Years After Initial Stroke, Journal of Pediatrics, 140, 3, 348-352.
Journal Article, Schatz, J., Brown, R.T., Pascual, J.M., Hsu, L., DeBaun, M.R. (2001), Poor School And Cognitive Functioning With Silent Cerebral Infarcts and Sickle Cell Disease, Neurology, 56, 8, 1109-1111.
Journal Article, Pegelow, C.H., Wang, W., Granger, S., Hsu, L.L., Vichinsky, E., Moser, F.G., Bello, J., Zimmerman, R.A., Adams, R.J., Brambilla, D. (2001), Silent Infarcts in Children With Sickle Cell Anemia and abnormal Cerebral Artery Velocity, Archives of Neurology, 58, 12, 2017-2021.
Journal Article, Brown, R.T., Davis, P.C., Lambert, R., Hsu, L., Hopkins, K., & Eckman, J. (2000), Neurocognitive Functioning and Magnetic Resonance Imaging in Children With Sickle Cell Disease, Journal of Pediatric Psychology, 25, 7, 503-513.
Journal Article, Walters, M.C., Storb R., Patience, M., Leisenring, W., Taylor, T., Sanders, J.E., Buchanan, G.R., Rogers, Z.R., Dinndorf, P., Davies, S.C., Roberts, I.A.G., Dickerhoff, R., Yeager, A.M., Hsu, L., Kurt (2000), Sullivan KM for the Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease. Impact of Bone Marrow Transplantation for Symptomatic Sickle Cell Disease: Long-Term Follow-up Ev, Blood, 95, 1918-1924.
Journal Article, Adams, R.J., McKie, V.C., Hsu, L.L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R., Brambilla, D. (1998), Transfusion Prevents First Stroke in Children with Sickle Cell Anemia and Abnormal Transcranial Doppler: The STOP Trial., New England Journal of Medicine, 339, 5-11.
For a more comprehensive list of publications for Lewis Hsu, MD, PhD view the National Library of Medicine’s PubMed online database |
|
|
|
|
|
|
